What’s Driving Growth in the Bleeding Disorder Testing Market? Insights into Key Trends and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the bleeding disorder testing market grown in recent years?
The bleeding disorder testing market has seen solid growth in recent years. It will increase from $14.99 billion in 2024 to $16.23 billion in 2025, at a CAGR of 8.3%. The growth is primarily driven by the rising prevalence of bleeding disorders, greater investment in R&D, more specialized clinics, increasing demand for early diagnoses, and a higher number of clinical trials.
How is the bleeding disorder testing market size expected to evolve during the forecast period?
The bleeding disorder testing market is expected to see significant growth, reaching $22.02 billion by 2029, with a CAGR of 7.9%. Growth is driven by the increasing prevalence of hemophilia, rising awareness of bleeding disorder symptoms, more investment in diagnostic research, higher healthcare spending, and the rising prevalence of rare bleeding disorders. Key trends include technological advancements, AI integration, personalized medicine, telemedicine services, and home-based testing kits.
Get your bleeding disorder testing market report here!
https://www.thebusinessresearchcompany.com/report/bleeding-disorder-testing-global-market-report
Which key drivers are propelling the bleeding disorder testing market’s growth?
The increasing number of clinical trials is expected to drive the growth of the bleeding disorder testing market. Clinical trials assess the safety and efficacy of new medical treatments, and their number is rising due to advancements in medical research and a demand for new therapies. Bleeding disorder testing plays a vital role in these trials by evaluating how new treatments affect clotting abnormalities. For instance, ClinicalTrials.gov reported 477,228 clinical trials were registered in 2023, an increase from 437,507 in 2022.
What are the market segments in the bleeding disorder testing industry?
The bleeding disorder testing market covered in this report is segmented –
1) By Product Type: Reagents And Consumables, Instruments
2) By Indication: Hemophilia A, Hemophilia B, Von Willebrand Disease, Idiopathic Thrombocytopenic Purpura, Other Indications
3) By Treatment Type: Factor Replacement Therapy, Drug Therapy
4) By End User: Hospitals And Clinics, Diagnostic Centers, Other End Users
Subsegments:
1) By Reagents And Consumables: Coagulation Reagents, Plasma And Blood Collection Consumables, Hemostasis Reagents, Factor Deficiency Assay Kits, Activated Partial Thromboplastin Time (APTT) Reagents
2) By Instruments: Coagulation Analyzers, Platelet Function Analyzers, Hemostasis Testing Instruments, Point-Of-Care Testing Devices, Automated Blood Testing Systems
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18263&type=smp
Which leading companies are shaping the growth of the bleeding disorder testing market?
Major companies operating in the bleeding disorder testing market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Takeda Pharmaceutical Company Limited, Novo Nordisk A/S, Siemens Healthcare GmbH, Baxter International Inc., CSL Limited, Octapharma AG, HORIBA Ltd., Haemonetics Corporation, Diagnostica Stago S.A.S., Sekisui Diagnostics LLC, Helena Laboratories Corporation, LFB Group, Sysmex Inostics GmbH, Medexus Pharmaceuticals Inc., Precision Biologics Inc., Corgenix Inc., Diapharma Group Inc., Hyphen BioMed, Hema Biologics LLC
What key trends are currently impacting the bleeding disorder testing market’s development?
Companies in the bleeding disorder testing market are focusing on developing groundbreaking products like gene therapy for Hemophilia B to offer long-term solutions. In February 2023, CSL Limited received approval for HEMGENIX, a one-time gene therapy for treating severe Hemophilia B. This treatment provides long-lasting efficacy by addressing the genetic defect causing the disorder and potentially changing the standard of care in hemophilia treatment.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18263
Which geographic areas are influencing the growth of the bleeding disorder testing market?
North America was the largest region in the bleeding disorder testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bleeding disorder testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Anemia And Other Blood Disorder Drugs Global Market Report 2024
Bleeding Disorders Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report
Neurodegenerative Disorder Therapeutics Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
